LOVASTATIN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where LOVASTATIN was used for Psoriasis.
Most Reported Side Effects for LOVASTATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug hypersensitivity | 217 | 15.7% | 0 | 1 |
| Myalgia | 192 | 13.8% | 2 | 17 |
| Drug ineffective | 137 | 9.9% | 2 | 76 |
| Completed suicide | 91 | 6.6% | 91 | 29 |
| Muscle spasms | 91 | 6.6% | 0 | 8 |
| Cerebrovascular accident | 81 | 5.8% | 1 | 69 |
| Myocardial infarction | 71 | 5.1% | 1 | 68 |
| Asthenia | 67 | 4.8% | 6 | 36 |
| Arthralgia | 63 | 4.5% | 0 | 10 |
| Disease progression | 59 | 4.3% | 56 | 13 |
| Diarrhoea | 57 | 4.1% | 0 | 15 |
| Toxicity to various agents | 57 | 4.1% | 49 | 27 |
| Rhabdomyolysis | 56 | 4.0% | 1 | 32 |
| Type iia hyperlipidaemia | 56 | 4.0% | 55 | 12 |
| Dizziness | 51 | 3.7% | 3 | 12 |
Other Indications for LOVASTATIN
Product used for unknown indication (392)
Blood cholesterol increased (128)
Type iia hyperlipidaemia (76)
Hyperlipidaemia (62)
Hypercholesterolaemia (53)
Low density lipoprotein abnormal (34)
Low density lipoprotein (30)
Blood cholesterol abnormal (24)
Blood cholesterol (22)
Dyslipidaemia (19)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)